Early surgical consultation in a multidisciplinary approach should be encouraged for patients with metastatic melanoma to optimize outcomes,” the researchers wrote.

Researchers sought to determine whether odronextamab would be effective in patients with DLBCL whose disease had progressed after CAR-T therapy.